Λίστα αντικειμένων
A recent study published in Blood advances "Evaluation of induction
chemotherapies after hypomethylating agent failure in myelodysplastic
syndromes and acute myeloid leukemia" was presented.
Induction led to response in 41% and 32%, survival of 10.8 and 6 months,
and transplant in 40% and 42% of responders in MDS and AML.
Treatment with high-dose cytarabine improved response rates in MDS and
an anthracycline-containing regimen increased survival in AML.
Presenter: Prof. Spyridonidis
Participants: Dr.Liga, Dr.Spyridis, Dr Aggelinas